Exercise Program for Fatty Liver Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This study will be a pilot study to evaluate the feasibility, safety and acceptability of Exercise and Liver FITness (EL-FIT), a mHealth exercise training program previously validated in patients with cirrhosis in patients with nonalcoholic steatohepatitis.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it does mention that active weight-loss supplement use is not allowed, except for GLP-1 receptor agonists.
Is exercise generally safe for people with fatty liver disease?
How is the Exercise Intervention with El-Fit App treatment unique for fatty liver disease?
The Exercise Intervention with El-Fit App is unique because it uses a telehealth-based approach to deliver exercise programs, making it more accessible and potentially more cost-effective than traditional face-to-face exercise programs. This method aims to increase physical activity among patients with fatty liver disease, who are often physically inactive, by providing personalized exercise guidance and support remotely.12367
What data supports the effectiveness of the treatment Exercise Intervention with El-Fit App for Fatty Liver Disease?
Research shows that increasing physical activity can improve liver health in people with fatty liver disease. Studies have found that exercise programs, including those delivered through web-based or telehealth platforms, can enhance physical fitness and improve liver enzyme levels, which are important for liver function.12358
Who Is on the Research Team?
Jonathan G Stine, MD
Principal Investigator
Penn State Health
Are You a Good Fit for This Trial?
This trial is for adults over 18 with nonalcoholic steatohepatitis (NASH), confirmed by a liver biopsy or certain tests within the last 6 months. Participants must own a smartphone to use the El-Fit App, which is part of the exercise program being tested.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the EL-FIT app and wear a Fitbit daily to engage in exercise as much or as little as they want
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Exercise Intervention with El-Fit App
Exercise Intervention with El-Fit App is already approved in United States, European Union, China for the following indications:
- Nonalcoholic Steatohepatitis
- Nonalcoholic Fatty Liver Disease
- Nonalcoholic Fatty Liver Disease
- Obesity-related conditions
- Nonalcoholic Fatty Liver Disease
- Central Obesity
Find a Clinic Near You
Who Is Running the Clinical Trial?
Milton S. Hershey Medical Center
Lead Sponsor